Cargando…

Characteristics of newly diagnosed COPD patients treated with triple inhaled therapy by general practitioners: a real world Italian study

Factors predicting prescriptions of triple therapy were investigated in a large group of general practitioners in Italy. In the population treated by identified general practitioners, a cohort of newly diagnosed chronic obstructive pulmonary disease patients was extracted from IMS Health Longitudina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Marco, Fabiano, Santus, Pierachille, Terraneo, Silvia, Peruzzi, Elena, Muscianisi, Elisa, Ripellino, Claudio, Pegoraro, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589801/ https://www.ncbi.nlm.nih.gov/pubmed/28883469 http://dx.doi.org/10.1038/s41533-017-0051-9

Ejemplares similares

A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management
por: Micheletto, Claudio, et al.
Publicado: (2019)

The role of phenotype on ventilation and exercise capacity in patients affected by COPD: a retrospective study
por: Rinaldo, Rocco F., et al.
Publicado: (2020)

Effects of aclidinium on determinants of COPD severity: symptoms and quality of life
por: Contoli, Marco, et al.
Publicado: (2016)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
por: Mantero, Marco, et al.
Publicado: (2018)

Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Monteagudo, Mònica, et al.
Publicado: (2021)

Day and Night Control of COPD and Role of Pharmacotherapy: A Review
por: Braghiroli, Alberto, et al.
Publicado: (2020)

Plethysmographic Loops: A Window on the Lung Pathophysiology of COPD Patients
por: Radovanovic, Dejan, et al.
Publicado: (2018)

The Airways' Mechanical Stress in Lung Disease: Implications for COPD Pathophysiology and Treatment Evaluation
por: Santus, Pierachille, et al.
Publicado: (2019)

Diagnostic Insights from Plethysmographic Alveolar Pressure Assessed during Spontaneous Breathing in COPD Patients
por: Zilianti, Camilla, et al.
Publicado: (2021)

Current appraisal of single inhaler triple therapy in COPD
por: Lipworth, Brian, et al.
Publicado: (2018)

Sublobar resection: functional evaluation and pathophysiological considerations
por: Santus, Pierachille, et al.
Publicado: (2020)

Pulmonary Rehabilitation in COPD: A Reappraisal (2008–2012)
por: Santus, Pierachille, et al.
Publicado: (2013)

Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
por: Kim, Sae Ahm, et al.
Publicado: (2016)

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
por: Bourbeau, Jean, et al.
Publicado: (2021)

Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
por: Di Marco, Fabiano, et al.
Publicado: (2018)

Disease awareness in patients with COPD: measurement and extent
por: Baiardini, Ilaria, et al.
Publicado: (2018)

Avoiding misdiagnosis in patients with dyspnea and wheezing: a case report illustrating the clinical implications of fixation error
por: Di Marco, Fabiano, et al.
Publicado: (2017)

Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
por: Di Marco, Fabiano, et al.
Publicado: (2018)

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
por: Dobler, Claudia C.
Publicado: (2018)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
por: Naya, Ian, et al.
Publicado: (2018)

Erratum: Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
Publicado: (2016)

Daily physical activity in subjects with newly diagnosed COPD
por: Van Remoortel, Hans, et al.
Publicado: (2013)

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
por: Resta, Emanuela, et al.
Publicado: (2022)

Comparison of newly diagnosed COPD patients and the non-COPD residents in Shanghai Minhang District
por: Yin, Xin, et al.
Publicado: (2023)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
por: Halpin, David M.G., et al.
Publicado: (2018)

Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
por: Fenwick, Elisabeth, et al.
Publicado: (2021)

Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial
por: Martin, Alan, et al.
Publicado: (2022)

Oxidative Stress and Respiratory System: Pharmacological and Clinical Reappraisal of N-Acetylcysteine
por: Santus, Pierachille, et al.
Publicado: (2014)

Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial
por: Santus, Pierachille, et al.
Publicado: (2015)

Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2020)

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
por: Tabberer, Maggie, et al.
Publicado: (2020)

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
por: Ismaila, Afisi S, et al.
Publicado: (2019)

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
por: Halpin, David M.G., et al.
Publicado: (2021)

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
por: Kiff, Chris, et al.
Publicado: (2018)

Early management of COPD: where are we now and where do we go from here? A Delphi consensus project
por: Di Marco, Fabiano, et al.
Publicado: (2019)

Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England
por: Rothnie, Kieran J, et al.
Publicado: (2022)

Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
por: Paly, Victoria Federico, et al.
Publicado: (2022)

Mucins and Asthma: Are We Headed to the Revolutionary Road?
por: Santus, Pierachille, et al.
Publicado: (2019)

Chronic obstructive lung disease “expert system”: validation of a predictive tool for assisting diagnosis
por: Braido, Fulvio, et al.
Publicado: (2018)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_asb7thab0i7l6qcq45crtsh3r3